Furthermore, since CDK6 display both kinase activity in cell cycle regulation and transcriptional regulation activity (14), it will be useful to investigate the oncogenic mechanism of CDK6 in urothelial carcinoma by either knockdown or overexpression of CDK6 in vitro experiment in the future. Here, CDK6 is linked to urothelial carcinoma.